Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | JAK2 | O60674 | 1/20 | 0.41 |
| ▸ | JAK3 | P52333 | 1/20 | 0.41 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.39 |
| ▸ | MAT2A | P31153 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | METAP2 | P50579 | 1/20 | 0.35 |
| ▸ | REN | P00797 | 2/20 | 0.34 |
| ▸ | USP14 | P54578 | 1/20 | 0.33 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CENPE | Q02224 | 1/20 | 0.32 |
| ▸ | KDR | P35968 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20904251 | 1.00 | KDM4E (0.47) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL20904455 | 0.99 | KDM4E (0.46) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL20904342 | 0.99 | KDM4E (0.46) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL20904454 | 0.99 | ATM (0.49) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL20904457 | 0.97 | KDM4E (0.44) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL20904345 | 0.97 | ATM (0.42) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL14000413 | 0.96 | KDM4E (0.51) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL20904358 | 0.95 | L3MBTL1 (0.43) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL20904432 | 0.95 | L3MBTL1 (0.43) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL20904360 | 0.95 | L3MBTL1 (0.43) | KDM4EATML3MBTL1JAK2JAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10937967-B2 | Amine-based compound and organic light-emitting device including the amine-based compound | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-03-02 | — | — | US | disclosed |
| US-20190115543-A1 | AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE AMINE-BASED COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10937967-B2 | Amine-based compound and organic light-emitting device including the amine-based compound | AOC2, AOC1, SAT1 | KDM4E 495/4885ATM 792/4885L3MBTL1 665/4885 |
| US-20190115543-A1 | AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE AMINE-BASED COMPOUND | AOC2, AOC1, SAT1 | KDM4E 495/4885ATM 792/4885L3MBTL1 665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.